---
schema_version: "secwatch.filing_event.v1"
accession: "0001804591-24-000045"
form_type: "8-K"
ticker: null
cik: "0001804591"
company_name: "Chrome Holding Co."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:08:45.899865+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# 23andMe Q1 FY25 revenue down 34% to $40M; net loss improves to $69M; ends Therapeutics Discovery

## Summary
- Revenue $40M, down 34% YoY due to lower research revenue after GSK exclusivity end and lower PGS kits/telehealth.
- Net loss $69M vs $105M; adjusted EBITDA loss $35M vs $50M.
- Cash $170M, down from $216M in prior quarter.
- Ceasing Therapeutics Discovery operations effective Aug 9; terminating 30 employees.
- Officer Bill Richards resigns effective Aug 23; severance includes $253.5K lump sum, COBRA, RSU acceleration of 90,265 RSUs.

## SEC filing metadata
- accession: 0001804591-24-000045
- form_type: 8-K
- cik: 0001804591
- company_name: Chrome Holding Co.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1804591/000180459124000045/0001804591-24-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1804591/000180459124000045/me-20240805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001804591-24-000045
- JSON: https://secwatch.observer/filing/0001804591-24-000045.json
- Plain text: https://secwatch.observer/filing/0001804591-24-000045.txt

## Key facts
- Executive change
  Bill Richards resigned as Head of Therapeutics Discovery at Chrome Holding Co..
  - Action: resigned
  - Role: Head of Therapeutics Discovery
  source text: On August 5, 2024, Bill Richards, the Head of Therapeutics Discovery, and a named executive officer of the Company, tendered his resignation to the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1804591/000180459124000045/0001804591-24-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.